person · Reporting owner

THOMAS H. LEE ADVISORS, LLC

Disclosed activity across 11 companies

Tapewire entity: 76088
SEC CIK: 0001260943

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Black Knight, Inc.BKI · Entity 172763	Director · 10% owner	September 29, 2017	October 03, 2017
Syneos Health, Inc.SYNH · Entity 109360	Director	June 07, 2021	June 09, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Black Knight, Inc.

Report date September 29, 2017 · Filed October 03, 2017

Jointly reported with THL Equity Fund VI Investors (BKFS-LM), LLC, THL Equity Fund VI Investors (BKFS-NB), LLC, Great-West Investors LP, Putnam Investments Employees' Securities Co III LLC, HAGERTY THOMAS M, Rao Gnaneshwar B.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	35,074,582	Reported balance Holding disclosure · report date 2017-09-29 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 35,074,582 F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3).
Common StockSEC Table I · non-derivative	Direct	36,699	Reported balance Holding disclosure · report date 2017-09-29 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 36,699 F4: See Exhibit 99.1 for text of footnote (4). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3). F6: See Exhibit 99.1 for text of footnote (6).
Common StockSEC Table I · non-derivative	Direct	7,719	Reported balance Holding disclosure · report date 2017-09-29 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 7,719 F4: See Exhibit 99.1 for text of footnote (4). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3). F6: See Exhibit 99.1 for text of footnote (6). F8: See Exhibit 99.1 for text of footnote (8).
Common StockSEC Table I · non-derivative	Direct	7,719	Reported balance Holding disclosure · report date 2017-09-29 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 7,719 F4: See Exhibit 99.1 for text of footnote (4). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3). F7: See Exhibit 99.1 for text of footnote (7). F8: See Exhibit 99.1 for text of footnote (8).

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1).

F2: See Exhibit 99.1 for text of footnote (2).

F3: See Exhibit 99.1 for text of footnote (3).

F4: See Exhibit 99.1 for text of footnote (4).

F5: See Exhibit 99.1 for text of footnote (5).

F6: See Exhibit 99.1 for text of footnote (6).

F7: See Exhibit 99.1 for text of footnote (7).

F8: See Exhibit 99.1 for text of footnote (8).

Syneos Health, Inc.

Report date June 07, 2021 · Filed June 09, 2021

Jointly reported with THL Fund VII Coinvestment Partners, L.P., THL Executive Fund VII, L.P., THL Equity Fund VII Investors (inVentiv), L.P.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	391,991	Reported balance After 2021-06-07 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-06-07 · Sale · Disposed 4,816,880 · Balance 391,991 F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3).
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	0	Reported balance After 2021-06-07 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2021-06-07 · Sale · Disposed 226,128 · Balance 0 F6: See Exhibit 99.1 for text of footnote (6). F7: See Exhibit 99.1 for text of footnote (7). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3).
Class A Common StockSEC Table I · non-derivative	Direct	37	Reported balance After 2021-06-07 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2021-06-07 · Sale · Disposed 815 · Balance 37 F8: See Exhibit 99.1 for text of footnote (8). F10: See Exhibit 99.1 for text of footnote (10).
Class A Common StockSEC Table I · non-derivative	Direct	14	Reported balance After 2021-06-07 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2021-06-07 · Sale · Disposed 313 · Balance 14 F9: See Exhibit 99.1 for text of footnote (9). F11: See Exhibit 99.1 for text of footnote (11).
Class A Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2021-06-07 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2021-06-07 · Sale · Disposed 37 · Balance 0 F12: See Exhibit 99.1 for text of footnote (12). F14: See Exhibit 99.1 for text of footnote (14).
Class A Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2021-06-07 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2021-06-07 · Sale · Disposed 14 · Balance 0 F13: See Exhibit 99.1 for text of footnote (13). F15: See Exhibit 99.1 for text of footnote (15).

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1).

F2: See Exhibit 99.1 for text of footnote (2).

F3: See Exhibit 99.1 for text of footnote (3).

F4: See Exhibit 99.1 for text of footnote (4).

F5: See Exhibit 99.1 for text of footnote (5).

F6: See Exhibit 99.1 for text of footnote (6).

F7: See Exhibit 99.1 for text of footnote (7).

F8: See Exhibit 99.1 for text of footnote (8).

F9: See Exhibit 99.1 for text of footnote (9).

F10: See Exhibit 99.1 for text of footnote (10).

F11: See Exhibit 99.1 for text of footnote (11).

F12: See Exhibit 99.1 for text of footnote (12).

F13: See Exhibit 99.1 for text of footnote (13).

F14: See Exhibit 99.1 for text of footnote (14).

F15: See Exhibit 99.1 for text of footnote (15).

Past disclosures · reporting ended (9)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

AGILITI, INC. \DE

Report date May 07, 2024 · Filed May 07, 2024

Jointly reported with THL AGILITI LLC, Thomas H. Lee Equity Fund VIII, L.P., Thomas H. Lee Parallel Fund VIII, L.P., THL Executive Fund VIII, L.P., THL FUND VIII COINVESTMENT PARTNERS, L.P., THL EQUITY ADVISORS VIII, LLC, THOMAS H LEE PARTNERS LP, THL HOLDCO, LLC, THL MANAGERS VIII, LLC

Section 16 reporting ended · disclosed 2024-05-07. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.0001 per shareSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2024-05-07 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2024-05-07 · Disposition to issuer · Disposed 98,195,398 · Balance 0 F1: See Exhibit 99.1 for text of Footnote 1. F2: See Exhibit 99.1 for text of Footnote 2. F3: See Exhibit 99.1 for text of Footnote 3. F4: See Exhibit 99.1 for text of Footnote 4.

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of Footnote 1.

F2: See Exhibit 99.1 for text of Footnote 2.

F3: See Exhibit 99.1 for text of Footnote 3.

F4: See Exhibit 99.1 for text of Footnote 4.

Black Knight, Inc.

Report date May 11, 2018 · Filed May 15, 2018

Section 16 reporting ended · disclosed 2017-10-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2018-05-11 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2018-05-11 · Sale · Disposed 12,074,582 · Balance 0 F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3).
Common StockSEC Table I · non-derivative	Direct	20,890	Reported balance Holding disclosure · report date 2018-05-11 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 20,890 F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3). F6: See Exhibit 99.1 for text of footnote (6).
Common StockSEC Table I · non-derivative	Direct	36,699	Reported balance Holding disclosure · report date 2018-05-11 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 36,699 F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3). F7: See Exhibit 99.1 for text of footnote (7).

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1).

F2: See Exhibit 99.1 for text of footnote (2).

F3: See Exhibit 99.1 for text of footnote (3).

F4: See Exhibit 99.1 for text of footnote (4).

F5: See Exhibit 99.1 for text of footnote (5).

F6: See Exhibit 99.1 for text of footnote (6).

F7: See Exhibit 99.1 for text of footnote (7).

Dayforce, Inc.

Report date August 28, 2020 · Filed August 31, 2020

Jointly reported with THL Equity Fund VI Investors (Ceridian) V, LLC, THL Equity Fund VI Investors (Ceridian) VI, L.P., THL Coinvestment Partners, L.P., THL Operating Partners, L.P., Great-West Investors LP, Putnam Investments Employees' Securities Co III LLC, HAGERTY THOMAS M, Rao Gnaneshwar B.

Section 16 reporting ended · disclosed 2020-02-21. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	0	Reported balance After 2020-08-28 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2020-08-28 · Sale · Disposed 7,217,347 · Balance 0 F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3).
Common StockSEC Table I · non-derivative	Direct	38,824	Reported balance Holding disclosure · report date 2020-08-28 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 38,824 F6: See Exhibit 99.1 for text of footnote (6). F9: See Exhibit 99.1 for text of footnote (9).
Common StockSEC Table I · non-derivative	Direct	129,656	Reported balance Holding disclosure · report date 2020-08-28 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 129,656 F7: See Exhibit 99.1 for text of footnote (7). F9: See Exhibit 99.1 for text of footnote (9).
Common StockSEC Table I · non-derivative	IndirectSee Footnote	114,235	Reported balance Holding disclosure · report date 2020-08-28 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 114,235 F8: See Exhibit 99.1 for text of footnote (8).

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1).

F2: See Exhibit 99.1 for text of footnote (2).

F3: See Exhibit 99.1 for text of footnote (3).

F4: See Exhibit 99.1 for text of footnote (4).

F5: See Exhibit 99.1 for text of footnote (5).

F6: See Exhibit 99.1 for text of footnote (6).

F7: See Exhibit 99.1 for text of footnote (7).

F8: See Exhibit 99.1 for text of footnote (8).

F9: See Exhibit 99.1 for text of footnote (9).

Dun & Bradstreet Holdings, Inc.

Report date August 26, 2025 · Filed August 26, 2025

Jointly reported with HAGERTY THOMAS M, Rao Gnaneshwar B.

Section 16 reporting ended · disclosed 2025-08-26. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2025-08-26 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2025-08-26 · Disposition to issuer · Disposed 22,525,103 · Balance 0 F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F5: See Exhibit 99.1 for text of footnote (5).
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2025-08-26 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2025-08-26 · Disposition to issuer · Disposed 42,949 · Balance 0 F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3). F4: See Exhibit 99.1 for text of footnote (4).
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2025-08-26 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2025-08-26 · Disposition to issuer · Disposed 42,949 · Balance 0 F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3). F4: See Exhibit 99.1 for text of footnote (4).
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2025-08-26 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2025-08-26 · Disposition to issuer · Disposed 58,210 · Balance 0 F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3). F4: See Exhibit 99.1 for text of footnote (4).

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1).

F2: See Exhibit 99.1 for text of footnote (2).

F3: See Exhibit 99.1 for text of footnote (3).

F4: See Exhibit 99.1 for text of footnote (4).

F5: See Exhibit 99.1 for text of footnote (5).

Federal Street Acquisition Corp.

Report date January 04, 2019 · Filed January 04, 2019

Section 16 reporting ended · disclosed 2019-01-04. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative	IndirectSee footnotes	0	Last balance in matching sequence After 2019-01-04 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2019-01-04 · Conversion · Acquired 11,400,000 · Balance 98,195,398 F1: See Exhibit 99.1 for text of footnotes. F3: See Exhibit 99.1 for text of footnotes. F4: See Exhibit 99.1 for text of footnotes. F5: See Exhibit 99.1 for text of footnotes. Row 2 · 2019-01-04 · Disposition to issuer · Disposed 98,195,398 · Balance 0 F2: See Exhibit 99.1 for text of footnotes. F3: See Exhibit 99.1 for text of footnotes. F4: See Exhibit 99.1 for text of footnotes. F5: See Exhibit 99.1 for text of footnotes.
Class F Common Stock, par value $0.0001 per shareSEC Table II · derivative / convertible security	IndirectSee footnotes	0	Reported balance After 2019-01-04 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-01-04 · Conversion · Disposed 11,400,000 · Balance 0 F1: See Exhibit 99.1 for text of footnotes. F3: See Exhibit 99.1 for text of footnotes. F4: See Exhibit 99.1 for text of footnotes. F5: See Exhibit 99.1 for text of footnotes.

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnotes.

F2: See Exhibit 99.1 for text of footnotes.

F3: See Exhibit 99.1 for text of footnotes.

F4: See Exhibit 99.1 for text of footnotes.

F5: See Exhibit 99.1 for text of footnotes.

Fogo de Chao, Inc.

Report date April 05, 2018 · Filed April 09, 2018

Jointly reported with THL Equity Fund VI Investors (Fogo) II, LLC, Great-West Investors LP, Putnam Investments Employees' Securities Co III LLC, Haber Douglas A., Swenson Jeff T., ABBRECHT TODD M

Section 16 reporting ended · disclosed 2018-04-09. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2018-04-05 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2018-04-05 · Sale · Disposed 17,149,323 · Balance 0 F2: See Exhibit 99.1 for text of footnote (2). F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3).

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1).

F2: See Exhibit 99.1 for text of footnote (2).

F3: See Exhibit 99.1 for text of footnote (3).

MONEYGRAM INTERNATIONAL INC

Report date December 09, 2019 · Filed December 10, 2019

Jointly reported with THL Managers VI, LLC

Section 16 reporting ended · disclosed 2019-12-10. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2019-12-09 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2019-12-09 · Sale · Disposed 30,006 · Balance 0 F4: See Exhibit 99.1 for text of footnote (4). F1: See Exhibit 99.1 for text of footnote (1). F5: See Exhibit 99.1 for text of footnote (5). F6: See Exhibit 99.1 for text of footnote (6). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3).

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1).

F2: See Exhibit 99.1 for text of footnote (2).

F3: See Exhibit 99.1 for text of footnote (3).

F4: See Exhibit 99.1 for text of footnote (4).

F5: See Exhibit 99.1 for text of footnote (5).

F6: See Exhibit 99.1 for text of footnote (6).

Party City Holdco Inc.

Report date November 12, 2019 · Filed November 14, 2019

Jointly reported with Thomas H. Lee Equity Fund VI, L.P., Thomas H. Lee Parallel Fund VI, L.P., Thomas H. Lee Parallel (DT) Fund VI, L.P., THL Coinvestment Partners, L.P., THL Operating Partners, L.P., THL PC Topco, L.P., THL Equity Fund VI Investors (PC), L.P., Great-West Investors LP, Putnam Investments Employees' Securities Co III LLC

Section 16 reporting ended · disclosed 2019-11-14. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2019-11-12 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2019-11-12 · Other · Disposed 35,716,258 · Balance 0 F4: See Exhibit 99.1 for text of footnote (4). F1: See Exhibit 99.1 for text of footnote (1). F5: See Exhibit 99.1 for text of footnote (5). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3).

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1).

F2: See Exhibit 99.1 for text of footnote (2).

F3: See Exhibit 99.1 for text of footnote (3).

F4: See Exhibit 99.1 for text of footnote (4).

F5: See Exhibit 99.1 for text of footnote (5).

iHeartMedia, Inc.

Report date May 01, 2019 · Filed May 03, 2019

Jointly reported with Clear Channel Capital IV, LLC, Clear Channel Capital V, L.P., CC CAPITAL V MANAGER, LLC, Carlisle James C., Grattan Laura A., SPERLING SCOTT M

Section 16 reporting ended · disclosed 2019-05-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common Stock, par value $0.001 per shareSEC Table I · non-derivative	IndirectSee footnotes	294,458.5	Reported balance After 2019-05-01 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2019-05-01 · Grant · Acquired 294,458.5 · Balance 294,458.5 F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3). F4: See Exhibit 99.1 for text of footnote (4). F7: See Exhibit 99.1 for text of footnote (7). F8: See Exhibit 99.1 for text of footnote (8).
Class B Common Stock, $0.001 par value per shareSEC Table II · derivative / convertible security	IndirectSee footnote	0	Reported balance After 2019-05-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-05-01 · Disposition to issuer · Disposed 277,778 · Balance 0 F9: See Exhibit 99.1 for text of footnote (9). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F5: See Exhibit 99.1 for text of footnote (5). F7: See Exhibit 99.1 for text of footnote (7).
Class C Common Stock, $0.001 par value per shareSEC Table II · derivative / convertible security	IndirectSee footnote	0	Reported balance After 2019-05-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-05-01 · Disposition to issuer · Disposed 29,483,751 · Balance 0 F9: See Exhibit 99.1 for text of footnote (9). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F6: See Exhibit 99.1 for text of footnote (6). F8: See Exhibit 99.1 for text of footnote (8).
WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	102,642	Reported balance After 2019-05-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-05-01 · Grant · Acquired 103,142 · Balance 102,642 F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3). F10: See Exhibit 99.1 for text of footnote (10). F11: See Exhibit 99.1 for text of footnote (11). F7: See Exhibit 99.1 for text of footnote (7). F8: See Exhibit 99.1 for text of footnote (8).

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1).

F2: See Exhibit 99.1 for text of footnote (2).

F3: See Exhibit 99.1 for text of footnote (3).

F4: See Exhibit 99.1 for text of footnote (4).

F5: See Exhibit 99.1 for text of footnote (5).

F6: See Exhibit 99.1 for text of footnote (6).

F7: See Exhibit 99.1 for text of footnote (7).

F8: See Exhibit 99.1 for text of footnote (8).

F9: See Exhibit 99.1 for text of footnote (9).

F10: See Exhibit 99.1 for text of footnote (10).

F11: See Exhibit 99.1 for text of footnote (11).

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 12, 2021 Filed May 14, 2021 21:56 UTC	Syneos Health, Inc. SYNH · Entity 109360	GrantClass A Common Stock	2,364	Not disclosed	Not disclosed	Disclosure SEC source: 0001140361-21-017530 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director ABBRECHT TODD M · CIK 0001260937 · Director Nelson Joshua M · CIK 0001375529 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,392 F7 · shares: See Exhibit 99.1 for text of footnote (7). F7 · price: See Exhibit 99.1 for text of footnote (7). F8 · price: See Exhibit 99.1 for text of footnote (8). Read SEC document
May 12, 2021 Filed May 18, 2021 21:49 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	25	$81.04	$2,026.00	Disclosure SEC source: 0001140361-21-017952 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 F8 · shares: See Exhibit 99.1 for text of footnote (8). F4 · price: See Exhibit 99.1 for text of footnote (4). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document
May 12, 2021 Filed May 18, 2021 21:49 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	64	$81.04	$5,186.56	Disclosure SEC source: 0001140361-21-017952 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852 F7 · shares: See Exhibit 99.1 for text of footnote (7). F4 · price: See Exhibit 99.1 for text of footnote (4). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document
May 12, 2021 Filed May 18, 2021 21:49 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	379,789	$81.04	$30,778,100.56	Disclosure SEC source: 0001140361-21-017952 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,208,835 F5 · shares: See Exhibit 99.1 for text of footnote (5). F4 · price: See Exhibit 99.1 for text of footnote (4). F6 · balance_after: See Exhibit 99.1 for text of footnote (6). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
May 12, 2021 Filed May 18, 2021 21:50 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	25	$81.04	$2,026.00	Disclosure SEC source: 0001140361-21-017953 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 F8 · shares: See Exhibit 99.1 for text of footnote (8). F4 · price: See Exhibit 99.1 for text of footnote (4). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document
May 12, 2021 Filed May 18, 2021 21:50 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	64	$81.04	$5,186.56	Disclosure SEC source: 0001140361-21-017953 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852 F7 · shares: See Exhibit 99.1 for text of footnote (7). F4 · price: See Exhibit 99.1 for text of footnote (4). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document
May 12, 2021 Filed May 18, 2021 21:50 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	379,789	$81.04	$30,778,100.56	Disclosure SEC source: 0001140361-21-017953 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,208,835 F5 · shares: See Exhibit 99.1 for text of footnote (5). F4 · price: See Exhibit 99.1 for text of footnote (4). F6 · balance_after: See Exhibit 99.1 for text of footnote (6). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
May 12, 2021 Filed May 20, 2021 21:45 UTC Amendment	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	25	$81.04	$2,026.00	Disclosure SEC source: 0001140361-21-018265 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 F8 · shares: See Exhibit 99.1 for text of footnote (8). F4 · price: See Exhibit 99.1 for text of footnote (4). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document
May 12, 2021 Filed May 20, 2021 21:45 UTC Amendment	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	64	$81.04	$5,186.56	Disclosure SEC source: 0001140361-21-018265 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852 F7 · shares: See Exhibit 99.1 for text of footnote (7). F4 · price: See Exhibit 99.1 for text of footnote (4). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document
May 12, 2021 Filed May 20, 2021 21:45 UTC Amendment	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	379,789	$81.04	$30,778,100.56	Disclosure SEC source: 0001140361-21-018265 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,208,871 F5 · shares: See Exhibit 99.1 for text of footnote (5). F4 · price: See Exhibit 99.1 for text of footnote (4). F6 · balance_after: See Exhibit 99.1 for text of footnote (6). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
May 12, 2021 Filed May 20, 2021 21:46 UTC Amendment	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	25	$81.04	$2,026.00	Disclosure SEC source: 0001140361-21-018266 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 F8 · shares: See Exhibit 99.1 for text of footnote (8). F4 · price: See Exhibit 99.1 for text of footnote (4). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document
May 12, 2021 Filed May 20, 2021 21:46 UTC Amendment	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	64	$81.04	$5,186.56	Disclosure SEC source: 0001140361-21-018266 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852 F7 · shares: See Exhibit 99.1 for text of footnote (7). F4 · price: See Exhibit 99.1 for text of footnote (4). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document
May 12, 2021 Filed May 20, 2021 21:46 UTC Amendment	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	379,789	$81.04	$30,778,100.56	Disclosure SEC source: 0001140361-21-018266 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,208,871 F5 · shares: See Exhibit 99.1 for text of footnote (5). F4 · price: See Exhibit 99.1 for text of footnote (4). F6 · balance_after: See Exhibit 99.1 for text of footnote (6). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
May 06, 2021 Filed May 10, 2021 21:27 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	12	$81.04	$972.48	Disclosure SEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 6 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352 F13 · shares: See Exhibit 99.1 for text of footnote F15 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document
May 06, 2021 Filed May 10, 2021 21:27 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	30	$81.04	$2,431.20	Disclosure SEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 916 F12 · shares: See Exhibit 99.1 for text of footnote F14 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document
May 06, 2021 Filed May 10, 2021 21:27 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	208	$81.04	$16,856.32	Disclosure SEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364 F9 · shares: See Exhibit 99.1 for text of footnote F11 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document
May 06, 2021 Filed May 10, 2021 21:27 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	544	$81.04	$44,085.76	Disclosure SEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 946 F8 · shares: See Exhibit 99.1 for text of footnote F10 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document
May 06, 2021 Filed May 10, 2021 21:27 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	183,292	$81.04	$14,853,983.68	Disclosure SEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,601,430 F6 · shares: See Exhibit 99.1 for text of footnote F7 · balance_after: See Exhibit 99.1 for text of footnote F1 · ownership.nature: See Exhibit 99.1 for text of footnote F2 · ownership.nature: See Exhibit 99.1 for text of footnote F3 · ownership.nature: See Exhibit 99.1 for text of footnote Read SEC document
May 06, 2021 Filed May 10, 2021 21:27 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	3,207,596	$81.04	$259,943,579.84	Disclosure SEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,899,055 F4 · shares: See Exhibit 99.1 for text of footnote F5 · balance_after: See Exhibit 99.1 for text of footnote F1 · ownership.nature: See Exhibit 99.1 for text of footnote F2 · ownership.nature: See Exhibit 99.1 for text of footnote F3 · ownership.nature: See Exhibit 99.1 for text of footnote Read SEC document
May 06, 2021 Filed May 10, 2021 21:30 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	12	$81.04	$972.48	Disclosure SEC source: 0001140361-21-016731 · form4.xml · nonDerivative · entry 6 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352 F13 · shares: See Exhibit 99.1 for text of footnote (13). F15 · balance_after: See Exhibit 99.1 for text of footnote (15). Read SEC document
May 06, 2021 Filed May 10, 2021 21:30 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	30	$81.04	$2,431.20	Disclosure SEC source: 0001140361-21-016731 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 916 F12 · shares: See Exhibit 99.1 for text of footnote (12). F14 · balance_after: See Exhibit 99.1 for text of footnote (14). Read SEC document
May 06, 2021 Filed May 10, 2021 21:30 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	208	$81.04	$16,856.32	Disclosure SEC source: 0001140361-21-016731 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document
May 06, 2021 Filed May 10, 2021 21:30 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	544	$81.04	$44,085.76	Disclosure SEC source: 0001140361-21-016731 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 946 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document
May 06, 2021 Filed May 10, 2021 21:30 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	183,292	$81.04	$14,853,983.68	Disclosure SEC source: 0001140361-21-016731 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,601,430 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
May 06, 2021 Filed May 10, 2021 21:30 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	3,207,596	$81.04	$259,943,579.84	Disclosure SEC source: 0001140361-21-016731 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director THL Executive Fund VII, L.P. · CIK 0001665668 · Director THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,899,055 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
March 10, 2021 Filed Mar 12, 2021 21:57 UTC	Dun & Bradstreet Holdings, Inc. DNB · Entity 76079	GrantClass A Common Stock	5,680	$0.00	$0.00	Disclosure SEC source: 0001140361-21-008406 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner HAGERTY THOMAS M · CIK 0001058835 · Director Rao Gnaneshwar B. · CIK 0001450650 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,512 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). Read SEC document
March 10, 2021 Filed Mar 12, 2021 21:57 UTC	Dun & Bradstreet Holdings, Inc. DNB · Entity 76079	GrantClass A Common Stock	5,680	$0.00	$0.00	Disclosure SEC source: 0001140361-21-008406 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner HAGERTY THOMAS M · CIK 0001058835 · Director Rao Gnaneshwar B. · CIK 0001450650 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,512 F5 · shares: See Exhibit 99.1 for text of footnote (5). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). Read SEC document
March 10, 2021 Filed Mar 12, 2021 21:56 UTC	Dun & Bradstreet Holdings, Inc. DNB · Entity 76079	GrantClass A Common Stock	5,680	$0.00	$0.00	Disclosure SEC source: 0001140361-21-008405 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,512 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). Read SEC document
March 10, 2021 Filed Mar 12, 2021 21:56 UTC	Dun & Bradstreet Holdings, Inc. DNB · Entity 76079	GrantClass A Common Stock	5,680	$0.00	$0.00	Disclosure SEC source: 0001140361-21-008405 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,512 F5 · shares: See Exhibit 99.1 for text of footnote (5). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:00 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	17	$74.18	$1,260.98	Disclosure SEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 6 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572 F13 · shares: See Exhibit 99.1 for text of footnote (13). F15 · balance_after: See Exhibit 99.1 for text of footnote (15). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:00 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	45	$74.18	$3,337.88	Disclosure SEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,490 F12 · shares: See Exhibit 99.1 for text of footnote (12). F14 · balance_after: See Exhibit 99.1 for text of footnote (14). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:00 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	242	$74.18	$17,950.35	Disclosure SEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:00 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	631	$74.18	$46,804.43	Disclosure SEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:00 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	277,114	$74.18	$20,554,930.95	Disclosure SEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,106,651 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:00 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	3,717,905	$74.18	$275,775,603.38	Disclosure SEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,517,640 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:01 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	17	$74.18	$1,260.98	Disclosure SEC source: 0001140361-21-007502 · form4.xml · nonDerivative · entry 6 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director · 10% owner THL Executive Fund VII, L.P. · CIK 0001665668 · Director · 10% owner THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572 F13 · shares: See Exhibit 99.1 for text of footnote (13). F15 · balance_after: See Exhibit 99.1 for text of footnote (15). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:01 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	45	$74.18	$3,337.88	Disclosure SEC source: 0001140361-21-007502 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director · 10% owner THL Executive Fund VII, L.P. · CIK 0001665668 · Director · 10% owner THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,490 F12 · shares: See Exhibit 99.1 for text of footnote (12). F14 · balance_after: See Exhibit 99.1 for text of footnote (14). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:01 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	242	$74.18	$17,950.35	Disclosure SEC source: 0001140361-21-007502 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director · 10% owner THL Executive Fund VII, L.P. · CIK 0001665668 · Director · 10% owner THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:01 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	631	$74.18	$46,804.43	Disclosure SEC source: 0001140361-21-007502 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director · 10% owner THL Executive Fund VII, L.P. · CIK 0001665668 · Director · 10% owner THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:01 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	277,114	$74.18	$20,554,930.95	Disclosure SEC source: 0001140361-21-007502 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director · 10% owner THL Executive Fund VII, L.P. · CIK 0001665668 · Director · 10% owner THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,106,651 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
March 03, 2021 Filed Mar 5, 2021 17:01 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	3,717,905	$74.18	$275,775,603.38	Disclosure SEC source: 0001140361-21-007502 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director · 10% owner THL Executive Fund VII, L.P. · CIK 0001665668 · Director · 10% owner THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,517,640 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
December 03, 2020 Filed Dec 7, 2020 17:05 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	174	$61.28	$10,662.72	Disclosure SEC source: 0001140361-20-027518 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 831 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document
December 03, 2020 Filed Dec 7, 2020 17:05 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	453	$61.28	$27,759.84	Disclosure SEC source: 0001140361-20-027518 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,166 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document
December 03, 2020 Filed Dec 7, 2020 17:05 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	2,771,132	$61.28	$169,814,968.96	Disclosure SEC source: 0001140361-20-027518 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,235,545 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
December 03, 2020 Filed Dec 7, 2020 17:09 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	174	$61.28	$10,662.72	Disclosure SEC source: 0001140361-20-027523 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director · 10% owner THL Executive Fund VII, L.P. · CIK 0001665668 · Director · 10% owner THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director · 10% owner ABBRECHT TODD M · CIK 0001260937 · Director Nelson Joshua M · CIK 0001375529 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 831 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document
December 03, 2020 Filed Dec 7, 2020 17:09 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	453	$61.28	$27,759.84	Disclosure SEC source: 0001140361-20-027523 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director · 10% owner THL Executive Fund VII, L.P. · CIK 0001665668 · Director · 10% owner THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director · 10% owner ABBRECHT TODD M · CIK 0001260937 · Director Nelson Joshua M · CIK 0001375529 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,166 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document
December 03, 2020 Filed Dec 7, 2020 17:09 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	2,771,132	$61.28	$169,814,968.96	Disclosure SEC source: 0001140361-20-027523 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner THL Fund VII Coinvestment Partners, L.P. · CIK 0001713702 · Director · 10% owner THL Executive Fund VII, L.P. · CIK 0001665668 · Director · 10% owner THL Equity Fund VII Investors (inVentiv), L.P. · CIK 0001713160 · Director · 10% owner ABBRECHT TODD M · CIK 0001260937 · Director Nelson Joshua M · CIK 0001375529 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,235,545 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document
September 17, 2020 Filed Sep 21, 2020 17:30 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	203	$59.26	$12,029.78	Disclosure SEC source: 0001140361-20-021021 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document
September 17, 2020 Filed Sep 21, 2020 17:30 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	529	$59.26	$31,348.54	Disclosure SEC source: 0001140361-20-021021 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,619 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document
September 17, 2020 Filed Sep 21, 2020 17:30 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	3,232,987	$59.26	$191,586,809.62	Disclosure SEC source: 0001140361-20-021021 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 16,006,677 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.